Loading...

Cochlear Limited

CHEOFPNK
Healthcare
Medical - Devices
$195.55
$2.51(1.30%)

Cochlear Limited (CHEOF) Stock Overview

Explore Cochlear Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.5/100

Key Financials

Market Cap12.8B
P/E Ratio54.86
EPS (TTM)$3.71
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Week$179.88
1 Month$173.75
3 Months$157.84
1 Year Target$233.76

CHEOF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cochlear Limited (CHEOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.76, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $233.76.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 54.86 and a market capitalization of 12.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;